EP3311168
NOVEL TNF STRUCTURE FOR USE IN THERAPY
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
22.10.2015EP published:
10.5.2023EP application number:
15784067.9
EPO information:
European Patent Register
Max expiry date:
21.10.2035
Title in English:
NOVEL TNF STRUCTURE FOR USE IN THERAPYLanguage of the patent:
English
Timeline
Today
22.10.2015EP application
10.5.2023EP Publication
Owner
Name:
UCB Biopharma SRLAddress:
Allée de la Recherche 60, 1070 Brussels, BE
Inventor
Name:
O'CONNELL, James PhilipAddress:
Slough Berkshire SL1 3WE, GB
Name:
PORTER, John RobertAddress:
Slough Berkshire SL1 3WE, GB
Name:
LAWSON, AlastairAddress:
Slough Berkshire SL1 3WE, GB
Name:
KROEPLIEN, BorisAddress:
Slough Berkshire SL1 3WE, GB
Name:
RAPECKI, Stephen EdwardAddress:
Slough Berkshire SL1 3WE, GB
Name:
NORMAN, Timothy JohnAddress:
Slough Berkshire SL1 3WE, GB
Name:
WARRELLOW, Graham JohnAddress:
Slough Berkshire SL1 3WE, GB
Name:
ARAKAKI, Tracy LynnAddress:
Slough Berkshire SL1 3WE, GB
Name:
BURGIN, Alex BuntinAddress:
Slough Berkshire SL1 3WE, GB
Name:
PITT, William RossAddress:
Slough Berkshire SL1 3WE, GB
Name:
CALMIANO, Mark DanielAddress:
Slough Berkshire SL1 3WE, GB
Name:
SCHUBERT, David AndreasAddress:
Slough Berkshire SL1 3WE, GB
Name:
LIGHTWOOD, Daniel JohnAddress:
Slough Berkshire SL1 3WE, GB
Name:
WOOTTON, Rebecca JayneAddress:
Slough Berkshire SL1 3WE, GB
Priority
Number:
201510758Date:
18.6.2015Country:
GB
Classification
Categories:
G01N 33/68, C07K 14/705, C07K 14/525, C07D 401/14, C07D 471/00